neurodiagnostics market analysis, neurodiagnostics market size, neurodiagnostics market share, neurodiagnostics market growth, neurodiagnostics market forecast, neurodiagnostics market trends, neurodiagnostics market report
How has the neurodiagnostics market evolved, and where is it heading next?
The neurodiagnostics market size has grown strongly in recent years. It will grow from $9.17 billion in 2024 to $9.82 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to rise in prevalence of neurological disorders, increase in adoption of advanced imaging technologies, growth in geriatric population, increase in awareness of early disease diagnosis, expanding healthcare infrastructure, and rise in investments in neuroscience research and development.
The neurodiagnostics market size is expected to see strong growth in the next few years. It will grow to $12.79 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing demand for non-invasive diagnostic techniques, growing prevalence of neurological disorders, rising government investments in healthcare infrastructure, rising awareness and early detection initiatives, and expansion of personalized medicine approaches. Major trends in the forecast period include development of portable EEG devices, integration of AI for improved diagnostic accuracy, enhanced MRI technologies for brain imaging, adoption of wearables for continuous monitoring, advancements in neurogenetic testing, and adoption of real-time data analytics for personalized treatment plans.
Get Your Free Sample of The Global Neurodiagnostics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20902&type=smp
What are the key drivers behind the rapid expansion of the neurodiagnostics market?
The increasing prevalence of neurological disorders is expected to drive the growth of the neurodiagnostics market going forward. Neurological disorders are conditions that impact the brain, spinal cord, or nerves, leading to various cognitive, motor, and sensory impairments. The rise in neurological disorders is largely due to aging populations, environmental factors, lifestyle changes, genetics, and better diagnostic techniques. Neurodiagnostics are essential for accurately identifying, assessing, and monitoring neurological disorders, enabling precise diagnosis, informed treatment decisions, and effective management of conditions affecting the brain, spinal cord, and nerves. For instance, in April 2023, according to the National Library of Medicine, a US-based medical library for medical research information, it was reported that, in 2023, 6.7 million Americans are affected by Alzheimer’s, and this number is expected to grow to 13.8 million by 2060. Therefore, the increasing prevalence of neurological disorders is driving the growth of the neurodiagnostics market.
What is the segmentation for the neurodiagnostics market?
The neurodiagnostics market covered in this report is segmented –
1) By Type: Diagnostic And Imaging Solutions, In-Vitro Diagnostics
2) By Technology: Neuroimaging Technologies, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Nuclear Medicine Imaging (PET, SPECT), Near Infrared Spectroscopic Imaging (NIRS), Electro-Encephalography (EEG), Magneto-Encephalography (MEG), Voxel Based Morphometry (VBM), Neuroinformatics
3) By Condition: Epilepsy, Alzheimer’s Disease, Parkinson’s Disease, Stroke, Joint Health, Other Conditions
4) By End Use : Hospitals And Clinics, Diagnostic Laboratories, Imaging Centers, Other End Uses
Subsegments:
1) By Diagnostic And Imaging Solutions: MRI (Magnetic Resonance Imaging) Systems, CT (Computed Tomography) Scanners, EEG (Electroencephalogram) Systems, EMG (Electromyography) Systems, MEG (Magnetoencephalography) Systems, PET (Positron Emission Tomography) Scanners, SPECT (Single Photon Emission Computed Tomography) Scanners, Functional MRI (fMRI) Systems, Intracranial Pressure Monitors
2) By In-Vitro Diagnostics: Blood-Based Diagnostics, Cerebrospinal Fluid (Csf) Analysis, Genetic Testing And Biomarkers, Neurochemical Diagnostics, Point-Of-Care Neurodiagnostics, Diagnostic Kits For Neurodegenerative Disorders
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/neurodiagnostics-global-market-report
Who are the most influential companies in the neurodiagnostics market?
Major companies operating in the neurodiagnostics market are Nihon Kohden Corporation, Cephalon LLC, Stratus Neuro LLC, Cadwell Industries Inc., Compumedics Limited, Ceribell Inc., CND Life Sciences Inc., Lifelines Neuro Inc., ANT Neuro B.V., Neurovative Diagnostics LLC, Firefly Neuroscience Inc, IntraNerve Neuroscience Inc, NeuroDiagnostics Laboratories LLC, Advanced Brain Monitoring Inc, Spes Medica S.r.l., BioSignal Group Inc, Combinostics Inc., Deymed Diagnostic LLC, NeuLine Health Inc., Ridge Diagnostics Inc., Beacon Biosignals Inc., Intch Inc.
How will emerging trends drive the neurodiagnostics market throughout the forecast period?
Major companies operating in the neurodiagnostics market are focusing on technological advancements such as an advanced software algorithm to enhance diagnostic accuracy and improve patient outcomes. An advanced software algorithm refers to a sophisticated set of instructions that processes and analyzes data using techniques such as artificial intelligence (AI) or machine learning to enhance decision-making and diagnostics. For instance, in October 2023, Ceribell Inc., a US-based medical equipment manufacturing company, launched the ClarityPro AI algorithm, marking a significant advancement in diagnosing electrographic status epilepticus (ESE). This state-of-the-art software, integrated into the Ceribell EEG system, leverages machine learning to analyze EEG waveforms and deliver real-time alerts for suspected seizures. Notably, ClarityPro is the first acute care device to receive FDA clearance for standalone diagnosis. This innovative technology is designed to improve clinical decision-making by continuously monitoring brain activity, offering actionable insights, and enabling faster and more effective treatment responses.
What are the major regional insights for the neurodiagnostics market, and which region holds the top position?
North America was the largest region in the neurodiagnostics market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurodiagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Neurodiagnostics Market Report 2025 Offer?
The neurodiagnostics market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Neurodiagnostics refers to the medical field focused on diagnosing and monitoring disorders of the nervous system, including the brain, spinal cord, and peripheral nerves. It involves the use of advanced technologies and tests to assess neurological function, identify abnormalities, and aid in the diagnosis of conditions such as epilepsy, stroke, multiple sclerosis, neuropathies, and other neurological diseases.?
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20902
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
